Mitomycin (M) in combination with cisplatin (P) or vinorelbine (V) and erythropoietin (Epo) in patients with in field relapse after radiation therapy of non-small cell lung cancer: A phase II study of the AIO

Frank Griesinger,I. Stenger,C. Tomala,U. Olgemoeller,W. Koerber,B. Fischer,Martin Sebastian,T. Overbeck

Mitomycin (M) in combination with cisplatin (P) or vinorelbine (V) and erythropoietin (Epo) in patients with in field relapse after radiation therapy of non-small cell lung cancer: A phase II study of the AIO

2007

Frank Griesinger
I. Stenger
C. Tomala
U. Olgemoeller
W. Koerber
B. Fischer
Martin Sebastian
T. Overbeck

18208 Background: Therapy for in radiation field relapse of NSCLC is challenging. Tumors are regularly resistant to chemotherapy, most likely due to a high proportion of hypoxic tumor. Mitomycin (M...

Keywords:

Erythropoietin
Vinorelbine
Cancer research
Cisplatin
Lung cancer
Radiation therapy
Medicine
Phases of clinical research
non small cell
in patient
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations